Hematuria in the Critically Ill Cancer Patients

  • Chukwuma O. Kalu
  • Ala AbudayyehEmail author
Reference work entry


Hematuria is a common problem caused by numerous diseases such as infection, urolithiasis, and increasingly malignancy. The finding can be burdensome to the patient and clinician alike due to the associated morbidities and challenges in diagnosing potentially life-threatening etiologies. A lack of a consensus on guidelines for evaluation persists which has complicated the physician’s decision-making process. This chapter reviews the current literature and seeks to highlight the current trends in diagnosis and outcomes particularly in critically ill cancer patients and special patient populations. Conclusively, prospective studies are needed to evaluate to streamline and update current guidelines for hematuria. Also, a structured and reflexive protocol across the system level will address the disparities and outcomes in certain demographic populations.


Microscopic hematuria Gross hematuria Asymptomatic microscopic hematuria Cost-effective Disparities Transplantation-associated microangiopathy American Urological Association Kidney transplant 


  1. 1.
    Abdullah Sumnu MG, Ozturk S. Primary glomerular diseases in the elderly. World J Nephrol. 2015;4(2): 263–70.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Alves M, Moreno R, Rodrigues F, et al. Hematuria as the first sign of multiple myeloma. Clin Case Rep. 2017;5(8):1358–61.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Ansari M, Vukicevic M, Rougemont AL, et al. Do NK cells contribute to the Pathophysiology of transplant-associated Thrombotic Microangiopathy? Am J Transplant. 2011;11(8):1748–52.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Avidor Y, Nadu A, Matzkin H. Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. Urology. 2000;55(1):22–4.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Bassett JC, Alvarez J, Koyama T, et al. Gender, race, and variation in the evaluation of microscopic hematuria among medicare beneficiaries. J Gen Intern Med. 2015;30(4):440–7.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Bell GM, Williams P, Thomson D. Is the loin pain and haematuria syndrome a renal manifestation of hypersensitivity? Lancet (London). 1984;1(8372):340.CrossRefGoogle Scholar
  7. 7.
    Bhuvanagiri AK, Kannan S, Gundupalli D, et al. Association between haematuria and urinary tract calculi. Eur Urol Suppl. 2018;17(5):e2230.CrossRefGoogle Scholar
  8. 8.
    Buteau A, Seideman CA, Svatek RS, et al. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol Semin Original Investig. 2014;32(2):128–34.CrossRefGoogle Scholar
  9. 9.
    Carvalho M, Velho PHI, Silva GBG, et al. A shocking hematuria. QJM Int J Med. 2015;108(1):55–7.CrossRefGoogle Scholar
  10. 10.
    Claudia Yuste EG, Sevillano AM, et al. Pathogenesis of glomerular haematuria. World J Nephrol. 2015;4(2):185–95.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Cohen RA, Brown RS. Microscopic Hematuria. N Engl J Med. 2003;348(23):2330–8.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Cohn JA, Vekhter B, Lyttle C, et al. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer. 2014;120(4):555–61.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Critchlow WA, Stern KL, Jameson JJ, et al. Retained nephrostomy string causing severe flank pain and hematuria. J Vasc Interv Radiol. 2017;28(9):1308–10.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Cui ZMD, Zhao JMD, Jia X-YP, et al. Clinical features and outcomes of anti–glomerular basement membrane disease in older patients. Am J Kidney Dis. 2011;57(4):575–82.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of Asymptomatic Microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6, Supplement):2473–81.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Elias K, Svatek RS, Gupta S, et al. High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer. 2010;116(12):2954–9.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Flagg L, Parish AL. Hematuria to bladder cancer management timeliness: a baseline study at a veterans affairs facility. J Nurs Pract. 2016;12(4):235–42.CrossRefGoogle Scholar
  18. 18.
    Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by Interferon Alfa-2b compared with Interferon Alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345(23):1655–9.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Fogazzi GB, Fogazzi GB, Ponticelli C, et al. Microscopic hematuria diagnosis and management. Nephron. 1996;72(2):125–34.PubMedCrossRefGoogle Scholar
  20. 20.
    Friedlander DF, Resnick MJ, You C, et al. Variation in the intensity of hematuria evaluation: a target for primary care quality improvement. Am J Med. 2014;127(7):633–640.e611.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Garg T, Pinheiro LC, Atoria CL, et al. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol. 2014;192(4):1072–7.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Gomez CR, Nomellini V, Faunce DE, et al. Innate immunity and aging. Exp Gerontol. 2008;43(8): 718–28.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy – Part I: definition, detection, prevalence, and etiology11The Asymptomatic Microscopic Hematuria in Adults Best Practice Policy has been published in summary format in American Family Physician, Volume 63, March 15, 2001. Urology. 2001;57(4): 599–603.PubMedCrossRefGoogle Scholar
  24. 24.
    Halpern JA, Chughtai B, Ghomrawi H. Cost-effectiveness of common diagnostic approaches for evaluation of asymptomatic microscopic hematuria. JAMA Intern Med. 2017;177(6):800–7.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Han SS, Ahn SY, Ryu J, et al. Proteinuria and hematuria are associated with acute kidney injury and mortality in critically ill patients: a retrospective observational study. BMC Nephrol. 2014;15(1):93.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Hassan EA, Ali TZ, Abdulbaki A, et al. Histopathologic findings of potential kidney donors with asymptomatic microscopic hematuria: impact on donation. Transplant Proc. 2017;49(8):1729–32.PubMedCrossRefGoogle Scholar
  27. 27.
    Hu R, Xing G, Wu H, et al. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases. Diagn Pathol. 2016;11(1):86.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Imai N, Shirai S, Shibagaki Y, et al. Nutcracker phenomenon in IgA nephropathy. Clin Kidney J. 2014;7(3):325–6.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Javanmard B, Yousefi MR, Fadavi B, et al. Retained surgical gauze presenting with gross hematuria: a case report. Urol J. 2017;14(5):5027–9.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Javanmard B, Haghighat Khah H, Fallah-Karkan M, et al. Recurrent hematuria in renal angio-venous malformation, delay diagnosis and endovascular treatment, a case report. Urol Case Rep. 2018;16:46–7.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Jimbo M. Evaluation and management of hematuria. Prim Care. 2010;37(3):461–72.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Johnson EK, Daignault S, Zhang Y, et al. Patterns of hematuria referral to urologists: does a gender disparity exist? Urology. 2008;72(3):498–502.PubMedCrossRefGoogle Scholar
  33. 33.
    Khan MA, Shaw G, Paris AMI. Is microscopic haematuria a urological emergency? BJU Int. 2002;90(4):355–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Kim S, Choi K, Huh K, et al. The significance of post-transplant microscopic hematuria in renal transplant patient. Transplantation. 2004;78(2):249–50.CrossRefGoogle Scholar
  35. 35.
    Knoll T. Epidemiology, pathogenesis, and pathophysiology of Urolithiasis. Eur Urol Suppl. 2010;9(12): 802–6.CrossRefGoogle Scholar
  36. 36.
    Kobayashi Y, Hiki Y, Kokubo T, et al. Steroid therapy during the early stage of progressive IgA nephropathy – a 10-year follow-up study. Nephron. 1996;72(2):237–42.PubMedCrossRefGoogle Scholar
  37. 37.
    Koratala A, Chamarthi G, Segal MS. Not all that is red is blood: a curious case of chromaturia. Clin Case Rep. 2018;6(6):1179–80.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Leaker BS, Leaker BR, Gordge MP, et al. Haemostatic changes in the loin pain and haematuria syndrome: secondary to renal vasospasm? QJM. 1990;76(281): 969–79.PubMedGoogle Scholar
  39. 39.
    Lech M, Anders H-J. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24(9):1357–66.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Lin J, Cheng Z, Qian Q. Elderly patients with glomerular diseases and IgA nephropathy. Nephrology. 2017;22(S4):20–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Locatelli F, Del Vecchio L, Pozzi C. The patient with IgA glomerulonephritis – what is the role of steroid treatment? Nephrol Dial Transplant. 1999;14(5): 1057–60.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Low AI, Matz LR. Hæmaturia and renal fornical lesions. Br J Urol. 1972;44(6):681–91.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Luo J-D, Liu B, Wang P, et al. External iliac vein – transplant ureteral fistula combined with renal cell carcinoma: an unusual case of hematuria. OncoTargets Ther. 2014;7:1339–42.Google Scholar
  44. 44.
    Ma Z, Liu X, Ning Y, et al. Nutcracker phenomenon in combination with glomerular nephritis in isolated hematuria patients. Int Urol Nephrol. 2013;45(3): 809–16.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Mariani AJ, Mariani MC, Macchioni C, et al. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989;141(2):350–5.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Mcdonald MM, Swagerty D, Wetzel L. Assessment of microscopic hematuria in adults. Am Fam Physician. 2006;73(10):1748–54.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Miller F, Lane BP, Kirsch M, et al. Loin pain-hematuria syndrome with a distinctive vascular lesion and alternative pathway complement activation. Arch Pathol Lab Med. 1994;118(10):1016–9.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Mishriki S. MP06-07 long-term outcome of hematuria – prospective large cohort. J Urol. 2018;199(4):e54.Google Scholar
  49. 49.
    Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma. N Engl J Med. 2007;356(2):115–24.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Muraoka N, Sakai T, Kimura H, et al. Rare causes of hematuria associated with various vascular diseases involving the upper urinary tract. Radiographics. 2008;28(3):855–67.PubMedCrossRefGoogle Scholar
  51. 51.
    Nasr SH, Fidler ME, Valeri AM, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2011;22(1):187–95.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Nieder AM, Lotan Y, Nuss GR, et al. Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urol Oncol Semin Original Invest. 2010;28(5):500–3.CrossRefGoogle Scholar
  53. 53.
    Nielsen M, Qaseem A, Amer Coll P, et al. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American college of physicians. Ann Intern Med. 2016;164(7):488–97.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Niemi MA, Cohen RA. Evaluation of microscopic hematuria: a critical review and proposed algorithm. Adv Chronic Kidney Dis. 2015;22(4):289–96.PubMedCrossRefGoogle Scholar
  55. 55.
    O’connor OJ, Mcsweeney SE, Maher MM. Imaging of hematuria. Radiol Clin N Am. 2008;46(1):113–32.PubMedCrossRefGoogle Scholar
  56. 56.
    Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol. 2001;166(5):1611–23.PubMedCrossRefGoogle Scholar
  57. 57.
    Paratore DA, Herts BR. Castleman disease. J Urol. 2015;194(2):529–30.PubMedCrossRefGoogle Scholar
  58. 58.
    Patel JV, Chambers CV, Gomella LG. Hematuria: etiology and evaluation for the primary care physician. Can J Urol. 2008;15:54–62.PubMedGoogle Scholar
  59. 59.
    Praga M, Martínez MA, Andrés A, et al. Association of thin basement membrane nephropathy with hypercalciuria, hyperuricosuria and nephrolithiasis. Kidney Int. 1998;54(3):915–20.PubMedCrossRefGoogle Scholar
  60. 60.
    Purpurowicz Z, Roslan M, Purpurowicz Ł, et al. Hematuria from urinary ascariasis. Kidney Int. 2017;91(6):1521.PubMedCrossRefGoogle Scholar
  61. 61.
    Raghavan R, Date A, Bhaktaviziam A. Fungal and nocardial infections of the kidney. Histopathology. 1987;11(1):9–20.PubMedCrossRefGoogle Scholar
  62. 62.
    Raman JD, Sosa RE, Vaughan ED, et al. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma. Urology. 2007;69(2):251–4.PubMedCrossRefGoogle Scholar
  63. 63.
    Ramirez D, Gupta A, Canter D, et al. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int. 2016;117(5):783–6.PubMedCrossRefGoogle Scholar
  64. 64.
    Richards KA, Ham S, Cohn JA, et al. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the medicare population: implications for sex disparities. Int J Urol. 2016;23(1):42–7.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Rivera-Sanchez R, Delgado-Ochoa D, Flores-Paz RR, et al. Prospective study of urinary tract infection surveillance after kidney transplantation. BMC Infect Dis. 2010;10(1):245.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Rockall AG, Newman-Sanders AP, Al-Kutoubi MA, et al. Haematuria. Postgrad Med J. 1997;73(857): 129–36.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Rodríguez Cabello MA, Sanz Miguelañez JL, Garrido Abad P, et al. Primary arteriocalicial fistula: a dangerously rare cause of hematuria. Urol Case Rep. 2018;19:18–9.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Samson P, Waingankar N, Shah P, et al. Predictors of genitourinary malignancy in patients with asymptomatic microscopic hematuria. Urol Oncol Semin Original Invest. 2018;36(1):10.e11–6.Google Scholar
  69. 69.
    Saundby R. The diagnostic significance of hematuria. Br Med J. 1887;2(1407):1320–4.PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Schmitz-Dräger BJ, Kuckuck EC, Zuiverloon TCM, et al. Microhematuria assessment an IBCN consensus – based upon a critical review of current guidelines. Urol Oncol Semin Original Invest. 2016;34(10): 437–51.CrossRefGoogle Scholar
  71. 71.
    Shinagare A, Silverman S, Gershanik E, et al. Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis. Am J Med. 2014;127(7): 625–32.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Siegler RL, Siegler RL, Brewer ED, et al. Platelet activation and prostacyclin supporting capacity in the loin pain hematuria syndrome. Am J Kidney Dis. 1988;12(2):156–60.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Smith HS, Bajwa ZH. Loin pain hematuria syndrome – visceral or neuropathic pain syndrome? Clin J Pain. 2012;28(7):646–51.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Subak LL, Grady D. Asymptomatic microscopic hematuria – rethinking the diagnostic algorithm. JAMA Intern Med. 2017;177(6):808–9.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Suzuki T, Imai N, Hisamichi M, et al. Can nutcracker phenomenon cause glomerular hematuria? Nephrology. 2018;23(5):495.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Taba Taba Vakili S, Alam T, Sollinger H. Loin pain hematuria syndrome. Am J Kidney Dis. 2014;64(3): 460–72.PubMedCrossRefGoogle Scholar
  77. 77.
    Tan WS, Feber A, Sarpong R, et al. Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients. Eur Urol. 2018;74(1):10–4.PubMedCrossRefGoogle Scholar
  78. 78.
    Tolofari SK, Chow W-M, Hussain B. Castleman’s disease: an interesting cause of hematuria. Urol Case Rep. 2015;3(2):24–6.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Tolofari S, Ansari A, Knight RJ. A rare case of hematuria; primary amyloidosis of the bladder neck. Urol Case Rep. 2017;10:48–50.PubMedCrossRefGoogle Scholar
  80. 80.
    Varma PP, Sengupta P, Nair RK. Post exertional hematuria. Ren Fail. 2014;36(5):701–3.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Virtamo J, Edwards BK, Virtanen M, et al. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control. 2000;11(10):933–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Wade H. A British medical association lecture on the significance of haematuria. Br Med J. 1932;1(3708): 177–80.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Wang Z, Vathsala A, Tiong HY. Haematuria in postrenal transplant patients. Biomed Res Int. 2015;2015:8.Google Scholar
  84. 84.
    Woolfson RG, Lewis CA, Hill PD, et al. Ureteric peristalsis studies in loin pain and haematuria syndrome: another diagnostic disappointment. Br J Urol. 1993;72(3):291–2.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Woolhandler S, Pels RJ, Bor DH, et al. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders: I. hematuria and proteinuria. JAMA. 1989;262(9):1214–9.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Ziemba J, Guzzo TJ, Ramchandani P. Evaluation of the patient with asymptomatic microscopic hematuria. Acad Radiol. 2015;22(8):1034–7.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Zubair AS, Salameh H, Erickson SB, et al. Loin pain hematuria syndrome. Clin Kidney J. 2016;9(1): 128–34.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.UTHealth and MD Anderson Cancer CenterHoustonUSA
  2. 2.Division of Internal Medicine, Section of NephrologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations